Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mark Doherty

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Gerontology|November 27, 2019
Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review)T Mark Doherty, Alberta Di Pasquale, Jean-Pierre Michel, et al.
Human Vaccines & Immunotherapeutics|July 4, 2023
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspectiveAshok Vaid, Neha Rastogi, T Mark Doherty, et al.
Journal of Immunological Methods|April 26, 2005
Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCRT Mark Doherty, Abebech Demissie, Dick Menzies, et al.
European Journal of Immunology|November 17, 2006
Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosisThomas Bennekov, Jes Dietrich, Ida Rosenkrands, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 14, 2024
Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: A scoping review and call to actionT Mark Doherty, Alberta Di Pasquale, Gary Finnegan, et al.
BMC Public Health|October 25, 2024
Burden of vaccine-preventable diseases in adults (50+) in the United States: a retrospective claims analysisMaximilian Hartmann, Nathalie Servotte, Emmanuel Aris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunityJes Dietrich, Claire Andersen, Rino Rappuoli, et al.
The Pediatric Infectious Disease Journal|September 20, 2016
Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young ChildrenSynne Jenum, Sivakumaran Dhanasekaran, Christian Ritz, et al.
The European Respiratory Journal|August 8, 2015
Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort studyNiaina Rakotosamimanana, Vincent Richard, Vaomalala Raharimanga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacyJes Dietrich, Claus Aagaard, Robert Leah, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Gerontology|November 27, 2019
Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review)T Mark Doherty, Alberta Di Pasquale, Jean-Pierre Michel, et al.
Human Vaccines & Immunotherapeutics|July 4, 2023
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspectiveAshok Vaid, Neha Rastogi, T Mark Doherty, et al.
Journal of Immunological Methods|April 26, 2005
Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCRT Mark Doherty, Abebech Demissie, Dick Menzies, et al.
European Journal of Immunology|November 17, 2006
Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosisThomas Bennekov, Jes Dietrich, Ida Rosenkrands, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 14, 2024
Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: A scoping review and call to actionT Mark Doherty, Alberta Di Pasquale, Gary Finnegan, et al.
BMC Public Health|October 25, 2024
Burden of vaccine-preventable diseases in adults (50+) in the United States: a retrospective claims analysisMaximilian Hartmann, Nathalie Servotte, Emmanuel Aris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunityJes Dietrich, Claire Andersen, Rino Rappuoli, et al.
The Pediatric Infectious Disease Journal|September 20, 2016
Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young ChildrenSynne Jenum, Sivakumaran Dhanasekaran, Christian Ritz, et al.
The European Respiratory Journal|August 8, 2015
Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort studyNiaina Rakotosamimanana, Vincent Richard, Vaomalala Raharimanga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacyJes Dietrich, Claus Aagaard, Robert Leah, et al.
Pageof 10